CHUA's Rectal Cancer Reference Center has a new website

Rectal Cancer is a public health problem with an important expression in Portugal

O Rectal Cancer Reference Center (CRCR) of the Centro Hospitalar Universitário do Algarve (CHUA) has a new website dedicated to this center and to colorectal pathology.

The month of March is the month of the “Blue March” Campaign, which aims to raise awareness of colorectal cancer, and therefore «we considered that it was the ideal time to launch this tool that aims to facilitate the approximation of health care to the population and the promotion of health literacy», explains Edgar Amorim, CHUA CRCR coordinator.

This website is divided into four main areas: the first is about the Reference Center, where information about the disease and associated services, such as consultations and hospitalization, is provided. In this area, we can also get to know the multidisciplinary team that makes up the CRCR.

The second area focuses essentially on the available complementary means of diagnosis, both in terms of radiology and gastroenterology. Next, the treatments area where the various treatment options, surgical and non-surgical, are presented.

“We can still find a fourth area, totally dedicated to the ostomized patient, where information, some teachings and care are provided and some prejudices about this situation are demystified”, says CHUA.

CHUA has been, since 2016, the Rectal Cancer Reference Center.

«We have since then had an experienced and highly qualified multidisciplinary team, which has specialized medical structures and equipment and which ensures that patient care is provided in accordance with the highest quality standards, in accordance with the most current evidence and the best recommendations from the scientific community», highlights the CRCR team.

Rectal Cancer is an important public health problem in Portugal, with a high incidence and significant associated morbidity and mortality. Together with colon cancer, it is the most common malignancy in both sexes, with an overall incidence rate of 70,3/100.000 inhabitants.

 



Comments

Ads